Abstract
Data from the United Arab Emirates about the mental health status of the younger population is limited. The current study aimed to assess the prevalence of anxiety, depression, and risk for PTSD among school students post lockdown of the current COVID-19 pandemic. A sample of 3745 students and their parents across the country answered a web-based survey. Parents provided bio-demographic data and students answered questions from the Mood and Feeling Questionnaire (MFQ-Child Self-report), Screen for Child Anxiety Related Disorders (SCARED-Child Version), and Children’s Revised Impact of Event Scale (CRIES-8). Findings showed that the risk for PTSD was the most prevalent (40.6%), followed by symptoms of anxiety (23.3%), and depression (17.1%). For gender differences, symptoms of the three conditions were higher in female students by 6.9%. Moreover, symptoms of depression and anxiety were found to be higher among late adolescents. Further analysis revealed that having medical problems (β = 2.0, p < 0.001) and witnessing the death of a close family member due to COVID-19 (β = 1.7, p < 0.001) were positive predictors associated with PTDS, depression, and anxiety. The study concluded that post COVID-19 lockdown, symptoms of anxiety, depression, and risk for PTSD are prevalent among students in the UAE. Researchers recommend the initiation of a national school mental health screening program and the provision of follow-up services for vulnerable students. Another must-have is the integration of a mental health support system in the emergency and disaster preparedness future plans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Research Committee of the Ministry of Health and Prevention gave ethical approval for this work. Approval Reference No: MOHAP/DXB-REC/ DDD/No.163 /2020 Institutional Review Board of the Emirates Review Board for COVID-19 Research gave ethical approval for this work. Approval Reference No:DOH/CVDC/2020/2471
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
